12:00 AM
 | 
Sep 05, 2005
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ACP-SL017: Phase I start

AAF will begin an open-label, dose-escalation, Phase I trial in patients to evaluate ACP-SL017 with and without photoactivation....

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >